Celldex Therapeutics (CLDX) Shares Outstanding (2010 - 2026)
Celldex Therapeutics' Shares Outstanding was 77.84 million in Q2 2026, up 17.2% from 66.39 million a year earlier and up 16.9% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Celldex Therapeutics came in at 66.42 million, up 3.1% from FY2024.
- Shares Outstanding has now increased for 16 consecutive years, with a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 64.4 million in FY2024 (+32.9%), 48.45 million in FY2023 (+3.3%), 46.89 million in FY2022 (+9.4%) and 42.87 million in FY2021 (+44.6%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding in data going back to Q2 2010.
- Compared with a year earlier, Shares Outstanding has increased for 61 straight quarters, with growth averaging 13.4% over the last eight quarters.
- The year-over-year growth in Shares Outstanding has ranged between 0.2% (Q3 2025) and 44.6% (Q4 2021) over the last five years.
- Per Business Quant data, CLDX's Shares Outstanding in the three quarters before Q2 2026 was 66.57 million (Q1 2026), 66.42 million (Q4 2025) and 66.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Celldex Therapeutics | 2.54 Bn | 2.54 Bn | - | 77.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.84 Mn |
| Mar 31, 2026 | 66.57 Mn |
| Dec 31, 2025 | 66.42 Mn |
| Sep 30, 2025 | 66.42 Mn |
| Jun 30, 2025 | 66.39 Mn |
| Mar 31, 2025 | 66.38 Mn |
| Dec 31, 2024 | 64.40 Mn |
| Sep 30, 2024 | 66.29 Mn |
| Jun 30, 2024 | 66.02 Mn |
| Mar 31, 2024 | 58.87 Mn |
| Dec 31, 2023 | 48.45 Mn |
| Sep 30, 2023 | 47.26 Mn |
| Jun 30, 2023 | 47.25 Mn |
| Mar 31, 2023 | 47.21 Mn |
| Dec 31, 2022 | 46.89 Mn |
| Sep 30, 2022 | 46.92 Mn |
| Jun 30, 2022 | 46.76 Mn |
| Mar 31, 2022 | 46.74 Mn |
| Dec 31, 2021 | 42.87 Mn |
| Sep 30, 2021 | 45.45 Mn |
API Access
Celldex Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();